We are live on
!
Find out more
Voloridge Investment Management Portfolio holdings
AUM
$25B
1-Year Est. Return
28.08%
This Fund
S&P 500
This Quarter
Est. Return
-0.68%
1 Year Est. Return
+28.08%
3 Year Est. Return
+85.2%
5 Year Est. Return
+73.43%
10 Year Est. Return
+582.16%
AUM
$15.5B
AUM Growth
+$1.1B
(+7.6%)
Cap. Flow
+$1.66B
Cap. Flow
% of AUM
10.71%
Top 10 Holdings %
Top 10 Hldgs %
8.52%
Holding
1,992
New
410
Increased
616
Reduced
582
Closed
382
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Micron Technology
MU
|
+$99.9M |
| 2 |
Cummins
CMI
|
+$92.4M |
| 3 |
Canadian Pacific Kansas City
CP
|
+$92.3M |
| 4 |
Intel
INTC
|
+$88.4M |
| 5 |
Norfolk Southern
NSC
|
+$88M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$245M |
| 2 |
Procter & Gamble
PG
|
+$148M |
| 3 |
Coca-Cola
KO
|
+$127M |
| 4 |
Nike
NKE
|
+$116M |
| 5 |
Thermo Fisher Scientific
TMO
|
+$108M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.14% |
| 2 | Healthcare | 14.38% |
| 3 | Industrials | 12.57% |
| 4 | Financials | 11.7% |
| 5 | Consumer Discretionary | 11.49% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
251
Editas Medicine
EDIT
$464M
| $17M | 0.11% |
414,664
+200,853
| +94% | +$11M |
|
252
Eli Lilly
LLY
$1.08T
| $17M | 0.11% |
+73,470
| New | +$18.1M |
|
253
BioCryst Pharmaceuticals
BCRX
$2.61B
| $17M | 0.11% |
1,180,297
+607,919
| +106% | +$9.59M |
|
|
254
Procter & Gamble
PG
$336B
| $16.9M | 0.11% |
120,857
-1,043,864
| -90% | -$148M |
|
255
Carrier Global
CARR
$53.1B
| $16.9M | 0.11% |
326,380
+235,750
| +260% | +$12.7M |
|
256
Array Technologies
ARRY
$841M
| $16.8M | 0.11% |
906,951
-45,869
| -5% | -$761K |
|
257
Sarepta Therapeutics
SRPT
$1.92B
| $16.7M | 0.11% |
181,067
-153,404
| -46% | -$11.8M |
|
|
BLDP
258
Ballard Power Systems
BLDP
$808M
| $16.7M | 0.11% |
1,188,617
+168,522
| +17% | +$2.67M |
|
259
Moody's
MCO
$83.2B
| $16.7M | 0.11% |
+46,936
| New | +$17.7M |
|
260
JetBlue
JBLU
$2.23B
| $16.6M | 0.11% |
1,084,079
+383,878
| +55% | +$5.89M |
|
|
REGI
261
DELISTED
Renewable Energy Group, Inc.
REGI
| $16.6M | 0.11% |
329,958
+96,531
| +41% | +$5.28M |
|
262
Jones Lang LaSalle
JLL
$16.7B
| $16.5M | 0.11% |
66,705
+39,182
| +142% | +$8.95M |
|
263
Merck
MRK
$324B
| $16.5M | 0.11% |
219,887
+217,279
| +8,331% | +$16.5M |
|
264
MasTec
MTZ
$22.9B
| $16.5M | 0.11% |
191,041
-23,125
| -11% | -$2.19M |
|
265
T. Rowe Price
TROW
$23.9B
| $16.4M | 0.11% |
+83,600
| New | +$17.6M |
|
266
Meta Platforms (Facebook)
META
$1.52T
| $16.3M | 0.11% |
+48,083
| New | +$17.3M |
|
267
MKS Inc
MKSI
$21.1B
| $16M | 0.1% |
106,267
+97,992
| +1,184% | +$15M |
|
268
Prologis
PLD
$132B
| $16M | 0.1% |
127,680
-25,658
| -17% | -$3.33M |
|
|
FITB
269
Fifth Third Bancorp
FITB
$52.3B
| $16M | 0.1% |
376,550
-175,815
| -32% | -$6.73M |
|
270
Winnebago Industries
WGO
$905M
| $15.9M | 0.1% |
220,145
+31,583
| +17% | +$2.21M |
|
271
Reinsurance Group of America
RGA
$15.9B
| $15.9M | 0.1% |
142,627
+90,935
| +176% | +$10.4M |
|
|
WCN
272
Waste Connections
WCN
$42B
| $15.8M | 0.1% |
125,294
-129,854
| -51% | -$16.4M |
|
273
Iovance Biotherapeutics
IOVA
$2.94B
| $15.7M | 0.1% |
638,434
-55,183
| -8% | -$1.3M |
|
|
STMP
274
DELISTED
Stamps.com, Inc.
STMP
| $15.7M | 0.1% |
+47,688
| New | +$15.1M |
|
275
Fastly Inc
FSLY
$4.8B
| $15.7M | 0.1% |
+388,393
| New | +$17.9M |
|
Similar funds
CS
VAI
Voloridge Investment Management's Q3 2021 Portfolio in Review
As of Q3 2021, Voloridge Investment Management held 1,992 positions worth $15.5B, up 7.6% from $14.4B the previous quarter. Its ten largest holdings account for 8.5% of the portfolio.
Voloridge Investment Management deployed $1.66B of net new capital in Q3 2021, opening 410 new positions and adding to 616 existing holdings. Its largest new stake was Berkshire Hathaway Class B: 290,340 shares worth $79.2M.
By sector, the portfolio is most concentrated in Technology at 19% of assets, down from 21% a quarter earlier, followed by Healthcare and Industrials.
On the sell side, the largest reduction was Apple, an estimated $245M trimmed.
- Voloridge Investment Management's largest Q3 2021 buy was Berkshire Hathaway Class B: 290,340 shares worth $79.2M.
- Voloridge Investment Management added most to Micron Technology in Q3 2021, an estimated $99.9M increase.
- Voloridge Investment Management's biggest Q3 2021 reduction was Apple, cutting an estimated $245M.
- Voloridge Investment Management fully exited Coca-Cola in Q3 2021, selling an estimated $127M.
- Voloridge Investment Management's ten largest holdings make up 8.5% of its $15.5B portfolio in Q3 2021.
- Voloridge Investment Management opened 410 new positions and closed 382 in Q3 2021.
- Voloridge Investment Management's portfolio value rose 7.6% quarter-over-quarter to $15.5B.
Based on Voloridge Investment Management's 13F filing for Q3 2021, filed 15 Nov 2021.